These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10572096

  • 1. Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activity.
    Pengo V, Brocco T, Biasiolo A, Rampazzo P, Carraro P, Zamarchi R.
    Blood; 1999 Dec 01; 94(11):3814-9. PubMed ID: 10572096
    [Abstract] [Full Text] [Related]

  • 2. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M, Finazzi G, Bevers EM, Barbui T.
    Blood; 1995 Jul 15; 86(2):617-23. PubMed ID: 7605991
    [Abstract] [Full Text] [Related]

  • 3. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V, Biasiolo A, Rampazzo P, Brocco T.
    Thromb Haemost; 1999 Feb 15; 81(2):256-8. PubMed ID: 10064002
    [Abstract] [Full Text] [Related]

  • 4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep 15; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 5. Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?
    Detkov, Gil-Aguado A, Lavilla P, Cuesta MV, Fontán G, Pascual-Salcedo D.
    Lupus; 1999 Sep 15; 8(6):430-8. PubMed ID: 10483010
    [Abstract] [Full Text] [Related]

  • 6. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y.
    Clin Chem; 2005 Mar 15; 51(3):545-52. PubMed ID: 15637132
    [Abstract] [Full Text] [Related]

  • 7. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V, Balestrieri G, Tincani A, Spatola L, Biasiolo A, Brocco T.
    Thromb Haemost; 1997 Jan 15; 77(1):123-6. PubMed ID: 9031461
    [Abstract] [Full Text] [Related]

  • 8. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE.
    Clin Exp Immunol; 2015 May 15; 180(2):218-26. PubMed ID: 25522978
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
    Galli M, Ruggeri L, Barbui T.
    Blood; 1998 Mar 15; 91(6):1999-2004. PubMed ID: 9490682
    [Abstract] [Full Text] [Related]

  • 10. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: immunological specificity and clotting profiles.
    Kandiah DA, Krilis SA.
    Lupus; 1998 Mar 15; 7(5):323-32. PubMed ID: 9696136
    [Abstract] [Full Text] [Related]

  • 11. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
    Sheng Y, Hanly JG, Reddel SW, Kouts S, Guerin J, Koike T, Ichikawa K, Sturgess A, Krilis SA.
    Clin Exp Immunol; 2001 Jun 15; 124(3):502-8. PubMed ID: 11472415
    [Abstract] [Full Text] [Related]

  • 12. Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I.
    Matsuda J, Gohchi K, Tsukamoto M, Saitoh N, Asami K, Hashimoto M.
    Am J Hematol; 1993 Nov 15; 44(3):187-91. PubMed ID: 8213768
    [Abstract] [Full Text] [Related]

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 15; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr 15; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 15. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants.
    Pengo V, Biasiolo A, Pegoraro C, Iliceto S.
    J Thromb Haemost; 2004 May 15; 2(5):702-7. PubMed ID: 15099274
    [Abstract] [Full Text] [Related]

  • 16. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG, Smith SA.
    J Rheumatol; 2000 Sep 15; 27(9):2152-9. PubMed ID: 10990227
    [Abstract] [Full Text] [Related]

  • 17. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov 15; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 18. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles.
    Galli M, Bevers EM, Comfurius P, Barbui T, Zwaal RF.
    Br J Haematol; 1993 Mar 15; 83(3):466-72. PubMed ID: 8485053
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA, Krilis SA.
    Thromb Haemost; 1998 Aug 15; 80(2):250-7. PubMed ID: 9716148
    [Abstract] [Full Text] [Related]

  • 20. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y.
    Thromb Haemost; 2004 May 15; 91(5):967-76. PubMed ID: 15116258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.